A research framework for pharmacovigilance in health social media: Identification and evaluation of patient adverse drug event reports

Xiao Liu, Hsinchun Chen

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

Social media offer insights of patients' medical problems such as drug side effects and treatment failures. Patient reports of adverse drug events from social media have great potential to improve current practice of pharmacovigilance. However, extracting patient adverse drug event reports from social media continues to be an important challenge for health informatics research. In this study, we develop a research framework with advanced natural language processing techniques for integrated and high-performance patient reported adverse drug event extraction. The framework consists of medical entity extraction for recognizing patient discussions of drug and events, adverse drug event extraction with shortest dependency path kernel based statistical learning method and semantic filtering with information from medical knowledge bases, and report source classification to tease out noise. To evaluate the proposed framework, a series of experiments were conducted on a test bed encompassing about postings from major diabetes and heart disease forums in the United States. The results reveal that each component of the framework significantly contributes to its verall effectiveness. Our framework significantly outperforms prior work.

Original languageEnglish (US)
Pages (from-to)268-279
Number of pages12
JournalJournal of Biomedical Informatics
Volume58
DOIs
StatePublished - Dec 1 2015

Keywords

  • Adverse drug event extraction
  • Health social media analytics
  • Information search and retrieval
  • Knowledge acquisition
  • Pharmacovigilance
  • Text mining

ASJC Scopus subject areas

  • Computer Science Applications
  • Health Informatics

Fingerprint

Dive into the research topics of 'A research framework for pharmacovigilance in health social media: Identification and evaluation of patient adverse drug event reports'. Together they form a unique fingerprint.

Cite this